Back to News
Market Impact: 0.3

Insilico's Lung Drug Reverses Aging Markers in Study

Source: Bloomberg

Artificial IntelligenceHealthcare & BiotechTechnology & Innovation

Insilico Medicine said an AI-discovered lung drug showed promise in reversing biological signs of aging, according to comments from founder and CEO Alex Zhavoronkov. The result supports the potential of AI-driven drug discovery in age-related disease research, though the article provides no clinical efficacy figures, trial-stage details, or financial impact.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.55

More News